Hidden-mortality risk among patients deemed“low-risk”following high-risk operations  

作　　者：Yongliang Sun Wenquan Niu Zhiying Yang 

机构地区：[1]Department of Hepatobiliary Surgery,China-Japan Friendship Hospital,Beijing,China [2]Institute of Clinical Medical Sciences,China-Japan Friendship Hospital,Beijing,China

出　　处：《Hepatobiliary Surgery and Nutrition》2022年第2期311-313,共3页肝胆外科与营养（英文）

摘　　要：In the surgical field,growing attention has been paid to the identification of patients with a particularly high predisposition to postoperative morbidity and mortality following high-risk operations.The hepatopancreatic operation is one of the most complex surgical procedures,and it places a heavy burden on individuals and public health systems.The latest statistics reveal that an estimated 40.5%of patients undergoing hepatopancreatic operation have experienced at least 1 postoperative complication,and about 1.3%of these patients died within 30 days(1).Given the high burden associated with high-risk operations,research efforts have shifted toward the identification and management of patients at the highest risk of morbidity and mortality,but have overlooked the hidden risk among patients labeled“low risk”by multiple prognostic tools(2,3).Whether such hidden risks merit special consideration or can be overlooked is currently an open question and the subject of ongoing debate.

关 键 词：PATIENTS MORTALITY operations 

分 类 号：R73[医药卫生—肿瘤]